Abstract
No public abstract is available from the verified source records.
Open public full textRights: UNKNOWN · cc-by-nc-nd · Source: journal-auto-sync:external:CROSSREF_ISSN
Ariel Siegel, Joseph Tripodi, Dianna Hardatt, Brianna Kelly, Sebastian El Ghaity-Beckley, Michelle Becker, Brenton Francisco, Kayleen Bailey, Bruce Petersen, Douglas Tremblay, Jonathan Feld, Hannah Levavi, Marina Kremyanskaya, Alla Keyzner, Bridget K. Marcellino, Christian Salib, Amy S. Duffield, John Mascarenhas, Vesna Najfeld, Alan H. Shih
Abstract
Rights: UNKNOWN · cc-by-nc-nd · Source: journal-auto-sync:external:CROSSREF_ISSN
Authors
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Eosinophilia in acute myeloid leukemia: overlooked and underexamined
10.1016/j.blre.2019.03.007 · 2019
M4 acute myeloid leukemia: the role of eosinophilia and cytogenetics in treatment response and survival. The GIMEMA experience
10.3324/haematol.11889 · 2008
Five years since the discovery of FIP1L1-PDGFRA: what we have learned about the fusion and other molecularly defined eosinophilias
10.1038/leu.2008.287 · 2008
ETV6 fusion genes in hematological malignancies: a review
10.1016/j.leukres.2012.04.010 · 2012
Characterization of leukemias with ETV6-ABL1 fusion
10.3324/haematol.2016.144345 · 2016
Cardiovascular manifestations of hypereosinophilic syndromes
10.1016/j.iac.2007.07.001 · 2007
IL-5 triggers a cooperative cytokine network that promotes eosinophil precursor maturation
10.4049/jimmunol.1400732 · 2014
A critical role for IL-18 in transformation and maturation of naive eosinophils to pathogenic eosinophils
10.1016/j.jaci.2018.02.011 · 2018
RUNX1 loss renders hematopoietic and leukemic cells dependent on IL-3 and sensitive to JAK inhibition
10.1172/jci167053 · 2023
A novel IL3-ETV6 fusion in chronic eosinophilic leukemia not otherwise specified with t(5; 12) (q31; p13): a case report and literature review
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
2022
Myeloid neoplasm with ETV6::ACSl6 fusion: landscape of molecular and clinical features
10.1080/16078454.2022.2117206 · 2022
ETV6::ACSL6 translocation-driven super-enhancer activation leads to eosinophilia in acute lymphoblastic leukemia through IL-3 overexpression
2024
Super-enhancers in the control of cell identity and disease
10.1016/j.cell.2013.09.053 · 2013
Super-enhancers and the super-enhancer reader BRD4: tumorigenic factors and therapeutic targets
10.1038/s41420-023-01775-6 · 2023
Activation of the interleukin-3 gene by chromosome translocation in acute lymphocytic leukemia with eosinophilia
10.1182/blood.v76.2.285.285 · 1990
Clinical utility of next generation sequencing to detect IGH/IL3 rearrangements [t(5;14)(q31.1;q32.1)] in B-lymphoblastic leukemia/lymphoma
10.1016/j.anndiagpath.2021.151761 · 2021
World Health Organization-defined eosinophilic disorders: 2014 update on diagnosis, risk stratification, and management
10.1002/ajh.23664 · 2014
Treatment of patients with the hypereosinophilic syndrome with mepolizumab
10.1056/nejmoa070812 · 2008
Jak1 integrates cytokine sensing to regulate hematopoietic stem cell function and stress hematopoiesis
10.1016/j.stem.2017.08.011 · 2017
No additional external references are available.